An announcement from Repare Therapeutics ( ($RPTX) ) is now available. Repare Therapeutics has announced a significant restructuring, reducing its ...

Experiments in mice showed that the drugs reduced the spread of breast cancer, suggesting a potential new approach to limiting metastasis. These drugs — known as Na+/K+ ATPase inhibitors — include ...

Repare Therapeutics is set to cut approximately 75% of its workforce as part of a restructuring plan aimed at extending its ...

The firm said its remaining employees will focus on developing the pol theta inhibitor RP-3467 and the PLK4 inhibitor RP-1664.

Our recently implemented re-structuring and the re-prioritization of our clinical portfolio meaningfully extends our cash runway into late ...

In connection with this we are also studying the role of the mitochondrial ATPase inhibitor protein IF1. This inhibitor has a probable role in the inhibition of ATPase activity in mitochondria under ...